Price targets on KBR, Inc. (NYSE: KBR), LKQ Co. (NASDAQ: LKQX), Mead Johnson Nutrition (NYSE: MJN), Oceaneering International (NYSE: OII) and Occidental Petroleum Co. (NYSE: OXY) get updated.
Jefferies (NYSE:JEF) raised their price target on shares of KBR, Inc. (KBR) from $33.00 to $42.00. They have a “hold” rating on the company.
Deutsche Bank (NYSE:DB) raised their price target on LKQ Co. (LKQX) from $20.00 to $27.50. They have a “hold” rating on the company.
Deutsche Bank raised their price target on Mead Johnson Nutrition (MJN) from $59.00 to $68.00.
Howard Weil raised their price target on Oceaneering International (OII) from $89.00 to $93.00. They have a “market perform” rating on the company.
Deutsche Bank raised their price target on Occidental Petroleum Co. (OXY) from $120.00 to $125.00.
Showing posts with label LKQ Corp. Show all posts
Showing posts with label LKQ Corp. Show all posts
Monday, May 2, 2011
Price Targets on (KBR) (LKQX) ( MJN) (HHS) (HLS) Updated
Price targets on KBR, Inc. (NYSE: KBR), LKQ Co. (NASDAQ: LKQX), Mead Johnson Nutrition (NYSE: MJN), Harte-Hanks, Inc. (NYSE: HHS) and HealthSouth (NYSE: HLS) get updated.
Jefferies (NYSE:JEF) raised their price target on KBR, Inc. (KBR) from $33.00 to $42.00. They have a “hold” rating on the company.
Deutsche Bank (NYSE:DB) raised their price target on LKQ Co. (LKQX) from $20.00 to $27.50. They have a “hold” rating on the company.
Deutsche Bank raised their price target on Mead Johnson Nutrition (MJN) from $59.00 to $68.00.
JPMorgan Chase & Co. (NYSE:JPM) cut their price target on Harte-Hanks, Inc. (HHS) from $15.00 to $11.00. They have a “neutral” rating on the company.
Jefferies raised their price target on HealthSouth (HLS) to $30.00.
Jefferies (NYSE:JEF) raised their price target on KBR, Inc. (KBR) from $33.00 to $42.00. They have a “hold” rating on the company.
Deutsche Bank (NYSE:DB) raised their price target on LKQ Co. (LKQX) from $20.00 to $27.50. They have a “hold” rating on the company.
Deutsche Bank raised their price target on Mead Johnson Nutrition (MJN) from $59.00 to $68.00.
JPMorgan Chase & Co. (NYSE:JPM) cut their price target on Harte-Hanks, Inc. (HHS) from $15.00 to $11.00. They have a “neutral” rating on the company.
Jefferies raised their price target on HealthSouth (HLS) to $30.00.
Price Targets (KBR) (LKQX) (MJN) (HHS) (HLS) Updated
Price targets on KBR, Inc. (NYSE: KBR), LKQ Co. (NASDAQ: LKQX), Mead Johnson Nutrition (NYSE: MJN), Harte-Hanks, Inc. (NYSE: HHS) and HealthSouth (NYSE: HLS) get updated.
Jefferies (NYSE:JEF) raised their price target on KBR, Inc. (KBR) from $33.00 to $42.00. They have a “hold” rating on the company.
Deutsche Bank (NYSE:DB) raised their price target on LKQ Co. (LKQX) from $20.00 to $27.50. They have a “hold” rating on the company.
Deutsche Bank raised their price target on Mead Johnson Nutrition (MJN) from $59.00 to $68.00.
JPMorgan Chase & Co. (NYSE:JPM) cut their price target on Harte-Hanks, Inc. (HHS) from $15.00 to $11.00. They have a “neutral” rating on the company.
Jefferies raised their price target on shares of HealthSouth (HLS) to $30.00.
Jefferies (NYSE:JEF) raised their price target on KBR, Inc. (KBR) from $33.00 to $42.00. They have a “hold” rating on the company.
Deutsche Bank (NYSE:DB) raised their price target on LKQ Co. (LKQX) from $20.00 to $27.50. They have a “hold” rating on the company.
Deutsche Bank raised their price target on Mead Johnson Nutrition (MJN) from $59.00 to $68.00.
JPMorgan Chase & Co. (NYSE:JPM) cut their price target on Harte-Hanks, Inc. (HHS) from $15.00 to $11.00. They have a “neutral” rating on the company.
Jefferies raised their price target on shares of HealthSouth (HLS) to $30.00.
Thursday, January 20, 2011
Acquisitions Drive LKQ Corp (NASDAQ:LKQX) PT, EPS Estimates Up
With over a dozen acquisitions in the last couple of quarters, LKQ Corp (NASDAQ:LKQX) had their price target and EPS estimates raised by Canaccord Genuity. 2011 revenue projections were also boosted.
Canaccord says, "LKQ completed seven acquisitions in Q3/10 and added another six or so in Q4/10, representing approximately $215M in combined annual revenue. To reflect these additions and a somewhat improved outlook for LKQ’s business overall, we increase our 2011 revenue estimate to $2.7B, up from $2.5 billion. As a result, our 2011 EPS estimate goes up to $1.35, from $1.28 previously. We introduce 2012 revenue/EPS estimates of $2.99B/$1.65."
Canaccord Genuity reiterates their "Hold" rating on LKQ Corp (LKQX), which closed Wednesday at $23.37, losing $0.19, or 0.81 percent. Canaccord raised their price target on LKQ from $21 to $25.
Canaccord says, "LKQ completed seven acquisitions in Q3/10 and added another six or so in Q4/10, representing approximately $215M in combined annual revenue. To reflect these additions and a somewhat improved outlook for LKQ’s business overall, we increase our 2011 revenue estimate to $2.7B, up from $2.5 billion. As a result, our 2011 EPS estimate goes up to $1.35, from $1.28 previously. We introduce 2012 revenue/EPS estimates of $2.99B/$1.65."
Canaccord Genuity reiterates their "Hold" rating on LKQ Corp (LKQX), which closed Wednesday at $23.37, losing $0.19, or 0.81 percent. Canaccord raised their price target on LKQ from $21 to $25.
Subscribe to:
Posts (Atom)